Eris Lifesciences Limited announced that the Board of Directors of the Company, in their meeting held on July 29, 2021, has approved declaration of interim dividend of INR 6.01 (at the rate of 601%) on each fully paid-up equity share of INR 1 for the Financial Year 2021-2022.